T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC

Oncogene

Volumn 24, Issue 22, 2005, Pages 3544-3553

  Smith, Darrin P ^a   Bath, Mary L ^a   Harris, Alan W ^a   Cory, Suzanne ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Haemopoiesis; Lymphoma; MYC; Progenitor; Transgenic

Indexed keywords

RAG1 PROTEIN; RECOMBINASE; VAV PROTEIN;

ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; BONE MARROW TUMOR; CARCINOGENESIS; CELL LINEAGE; CELL SIZE; GENE EXPRESSION; GENE OVEREXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LYMPHOID CELL; MACROPHAGE; MALIGNANT TRANSFORMATION; MEGAKARYOCYTE; MONOCYTE; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; REGULATORY SEQUENCE; T CELL LYMPHOMA; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENETIC VECTORS; HEMATOLOGIC NEOPLASMS; HUMANS; LYMPHOMA, T-CELL; MEGAKARYOCYTES; MICE; MICE, TRANSGENIC; MONOCYTES; MYELOID CELLS; PROTO-ONCOGENE PROTEINS C-MYC; SIMIAN VIRUS 40; TRANSGENES;

MUS MUSCULUS;

EID: 19944369765     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208399     Document Type: Article

References (42)

1. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD and Brinster RL. (1985). Nature, 318, 533-538.
2. Adams JM, Harris AW, Strasser A, Ogilvy S and Cory S. (1999). Oncogene, 18, 5268-5277.
3. Bath ML. (2003). Biol. Reprod., 68, 19-23.
4. Boxer LM and Dang CV. (2001). Oncogene, 20, 5595-5610.
5. Ceredig R and Rolink T. (2002). Nat. Rev. Immunol., 2, 888-897.
6. Cory S. (1986). Adv. Cancer Res., 47, 189-234.
7. Egle A, Harris AW, Bouillet P and Cory S. (2004). Proc. Natl. Acad. Sci. USA, 101, 6164-6169.
8. Eischen CM, Weber JD, Roussel MF, Sherr CJ and Cleveland JL. (1999). Genes Dev., 13, 2658-2669.
9. Elghetany MT. (1997). Leukemia, 11, 762-764.
10. Evan G and Littlewood T. (1998). Science, 281, 1317-1321.
11. Felsher DW and Bishop JM. (1999). Mol. Cell, 4, 199-207.
12. Grandori C, Cowley SM, James LP and Eisenman RN. (2000). Ann. Rev. Cell Dev. Biol., 16, 653-699.
13. Hann B and Balmain A. (2001). Curr. Opin. Cell Biol., 13, 778-784.
14. Hardy RR and Hayakawa K. (2001). Ann. Rev. Immunol., 19, 595-621.
15. Harris AW, Pinkert CA, Crawford M, Langdon WY, Brinster RL and Adams JM. (1988). J. Exp. Med., 167, 353-371.
16. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B and Gatter KC. (1994). Blood, 84, 1361-1392.
17. Iritani BM and Eisenman RN. (1999). Proc. Natl. Acad. Sci. USA, 96, 13180-13185.
18. Langdon WY, Harris AW, Cory S and Adams JM. (1986). Cell, 47, 11-18.
19. Maljaie SH, Brito-Babapulle V, Matutes E, Hiorns LR, De Schouwer PJ and Catovsky D. (1995). Leukemia, 9, 1694-1699.
20. Marcu KB, Bossone SA and Patel AJ. (1992). Ann. Rev. Biochem., 61, 809-860.
21. Marsden V and Strasser A. (2003). Ann. Rev. Immunol., 21, 71-105.
22. Michie AM and Zuniga-Pflucker JC. (2002). Semin. Immunol., 14, 311-323.
23. Mikkers H and Berns A. (2003). Adv. Cancer Res., 88, 53-99.
24. Min B, McHugh R, Sempowski GD, Mackall C, Foucras G and Paul WE. (2003). Immunity, 18, 131-140.
25. Mombaerts P, Clark AR, Rudnicki MA, Iacomini J, Itohara S, Lafaille JJ, Wang L, Ichikawa Y, Jaenisch R, Hooper ML and Tonegawa S. (1992a). Nature, 360, 225-231.
26. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S and Papaioannou VE. (1992b). Cell, 68, 869-877.
27. Morse III HC, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Jaffe ES, Kogan SC, MacLennan IC, Pattengale PK and Ward JM. (2002). Blood, 100, 246-258.
28. Nehls M, Pfeifer D, Schorpp M, Hedrich H and Boehm T. (1994). Nature, 372, 103-107.
29. Ogilvy S, Metcalf D, Gibson L, Bath ML, Harris AW and Adams JM. (1999a). Blood, 94, 1855-1863.
30. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW and Adams JM. (1999b). Proc. Natl. Acad. Sci. USA, 96, 14943-14948.
31. Pekarsky Y, Hallas C and Croce CM. (2001). JAMA, 286, 2308-2314.
32. Renno T, Attinger A, Rimoldi D, Hahne M, Tschopp J and MacDonald HR. (1998). Eur. J. Immunol., 28, 540-547.
33. Sanchez-Beato M, Sanchez-Aguilera A and Piris MA. (2003). Blood, 101, 1220-1235.
34. Schmitt CA. (2003). Nat. Rev. Cancer, 3, 286-295.
35. Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR and Lowe SW. (1999). Genes Dev., 13, 2670-2677.
36. Schmitt CA, Rosenthal CT and Lowe SW. (2000). Nat. Med., 6, 1029-1035.
37. Shou Y, Martelli ML, Gabrea A, Qi Y, Brents LA, Roschke A, Dewald G, Kirsch IR, Bergsagel PL and Kuehl WM. (2000). Proc. Natl. Acad. Sci. USA, 97, 228-233.
38. Spanopoulou E, Roman CAJ, Corcoran LM, Schlissel MS, Silver DP, Nemazee D, Nussenzweig MC, Shinton SA, Hardy RA and Baltimore D. (1994). Genes Dev., 8, 1030-1042.
39. Stewart M, Cameron E, Campbell M, McFarlane R, Toth S, Lang K, Onions D and Neil JC. (1993). Int. J. Cancer, 53, 1023-1030.
40. Strasser A, Elefanty AG, Harris AW and Cory S. (1996). EMBO J., 15, 3823-3834.
41. Strasser A, Harris AW, Bath ML and Cory S. (1990). Nature, 348, 331-333.
42. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG and Murray R. (1995). J. Exp. Med., 181, 1519-1526.